Back to News
Market Impact: 0.35

Starbucks vs. Dutch Bros: Which Coffee Stock is a Better Buy Now?

SBUXBROSNVDA
Company FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsConsumer Demand & RetailTechnology & InnovationManagement & Governance
Starbucks vs. Dutch Bros: Which Coffee Stock is a Better Buy Now?

Starbucks is facing significant operational headwinds, with Q3 FY25 non-GAAP operating margin contracting 660 basis points to 10.1% and global comparable sales declining 2%, leading to a projected 33.2% EPS decline for fiscal 2025. In contrast, Dutch Bros is in a high-growth phase, targeting 160 new shop openings in 2025 towards a 2,000-location goal by 2029, and is projected to achieve a 34.7% increase in FY25 EPS alongside a 37% rise in Q2 2025 adjusted EBITDA. This divergence positions Dutch Bros as a more favorable investment given its rapid expansion and stronger earnings momentum, while Starbucks navigates a challenging multi-year turnaround.

Analysis

The U.S. coffee retail sector is exhibiting a clear divergence between incumbent Starbucks (SBUX) and growth-challenger Dutch Bros (BROS). Starbucks is navigating a difficult multi-year turnaround, facing significant operational and financial headwinds. This is quantified by a 660 basis point year-over-year contraction in its non-GAAP operating margin to 10.1% in Q3 FY25, driven by rising costs that management expects to persist into 2026. The company's top line is also under pressure, with global comparable sales falling 2% and U.S. transactions declining 3%. This weakness is reflected in analyst expectations, with the Zacks Consensus Estimate for fiscal 2025 pointing to a 33.2% decline in EPS, accompanied by a 12% downward revision over the past 60 days. In stark contrast, Dutch Bros is in an aggressive and successful expansion phase. The company is executing on a plan to open 160 new shops in 2025 as it targets over 2,000 locations by 2029. This growth is profitable, as evidenced by a 37% year-over-year increase in adjusted EBITDA in Q2 2025. The outlook for BROS is exceptionally strong, with consensus estimates projecting 25.1% sales growth and 34.7% EPS growth for 2025, supported by an 11.9% upward revision in earnings estimates. This performance commands a premium valuation, with BROS trading at a forward P/S of 6.44X, while SBUX trades at a discount to the industry at 2.52X.

AllMind AI Terminal